Disciplined capital for the cannabis transition.
CONCORDCANNABISCAPITAL.COM is available for purchase. One possible direction: a cannabis-focused venture capital and growth equity firm deploying patient capital into licensed Canadian operators, cannabis-adjacent technology, and international expansion plays at the Series A through C stage.
Fund I · Portfolio snapshot
Investment thesis
Three mandates that define where Concord Cannabis Capital deploys.
01
Licensed operators
Growth equity into Health Canada licensed producers, processors, and retailers with demonstrated revenue, defensible unit economics, and a path to profitability within 24 months of investment. Preference for companies with proprietary genetics, formats, or distribution advantages.
02
Cannabis-adjacent technology
Seed and Series A in technology companies whose primary customer is the cannabis industry: compliance software, cultivation technology, retail analytics, supply chain platforms, and lab services. Cannabis-tech carries different risk than plant-touching operators.
03
International expansion
Strategic capital for Canadian operators entering Germany, Australia, and emerging regulated markets. Canadian LPs with federal export licences and EU-GMP certification are positioned to supply international medical markets as regulatory frameworks mature.
$42M
Assets under management
11
Portfolio companies
2.1×
Gross MOIC on realized exits
3
Investment mandates
Who we work with
For founders, LPs, and operators navigating the cannabis capital market.
Cannabis operators seeking capital
Licensed producers, retailers, and cannabis-tech founders raising Series A through C rounds who want an investor with sector expertise, a network of co-investors who understand the regulatory environment, and patient capital structured for cannabis timelines.
Limited partners
Family offices, endowments, and high-net-worth investors seeking dedicated cannabis exposure through a professionally managed vehicle. The fund provides diversification across operators, technology, and geographies that individual direct investments cannot replicate efficiently.
Strategic co-investors
Cannabis industry participants, licensed producers, and strategic buyers who want to co-invest alongside the fund on specific portfolio companies. Co-investment rights offered to LPs above threshold, with deal-by-deal syndication available to qualified strategic partners.
The asset is the address
Purchase CONCORDCANNABISCAPITAL.COM.
Send a note. Offers, partnerships, and serious enquiries are read by the owner directly. Brokers welcome. Confidentiality assumed.
Common questions about concordcannabiscapital.com
Is concordcannabiscapital.com available for purchase?
concordcannabiscapital.com is currently available for purchase. Use the contact form to send an enquiry. Brokers are welcome and confidentiality is assumed on all enquiries.
How do I make an offer on concordcannabiscapital.com?
Use the contact form on this page with your offer or message. The owner reads all enquiries personally and responds to serious offers promptly.
Who is selling concordcannabiscapital.com?
concordcannabiscapital.com is held by a private domain portfolio based in British Columbia, Canada. The domain is available for transfer to any qualified buyer worldwide.